Go to The Journal of Clinical Investigation
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Transfers
  • Advertising
  • Job board
  • Contact
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Immunology
    • Metabolism
    • Nephrology
    • Oncology
    • Pulmonology
    • All ...
  • Videos
  • Collections
    • Resource and Technical Advances
    • Clinical Medicine
    • Reviews
    • Editorials
    • Perspectives
    • Top read articles
  • JCI This Month
    • Current issue
    • Past issues

  • Current issue
  • Past issues
  • Specialties
  • In-Press Preview
  • Concise Communication
  • Editorials
  • Viewpoint
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Transfers
  • Advertising
  • Job board
  • Contact
Angiotensin II triggers release of neutrophil extracellular traps, linking thromboinflammation with essential hypertension
Akrivi Chrysanthopoulou, … , Konstantinos Ritis, Panagiotis Skendros
Akrivi Chrysanthopoulou, … , Konstantinos Ritis, Panagiotis Skendros
Published July 29, 2021
Citation Information: JCI Insight. 2021;6(18):e148668. https://doi.org/10.1172/jci.insight.148668.
View: Text | PDF
Research Article Immunology Inflammation

Angiotensin II triggers release of neutrophil extracellular traps, linking thromboinflammation with essential hypertension

  • Text
  • PDF
Abstract

Innate immunity and chronic inflammation are involved in atherosclerosis and atherothrombosis, leading to target organ damage in essential hypertension (EH). However, the role of neutrophils in EH is still elusive. We investigated the association between angiotensin II (Ang II) and neutrophil extracellular traps (NETs) in pathogenesis of EH. Plasma samples, kidney biopsies, and surgical specimens of abdominal aortic aneurysms (AAAs) from patients with EH were used. Cell-based assays, NETs/human aortic endothelial cell cocultures, and in situ studies were performed. Increased plasma levels of NETs and tissue factor (TF) activity were detected in untreated, newly diagnosed patients with EH. Stimulation of control neutrophils with plasma from patients with untreated EH generated TF-enriched NETs promoting endothelial collagen production. Ang II induced NETosis in vitro via an ROS/peptidylarginine deiminase type 4 and autophagy-dependent pathway. Circulating NETs and thrombin generation levels were reduced substantially in patients with EH starting treatment with Ang II receptor blockers, whereas their plasma was unable to trigger procoagulant NETs. Moreover, TF-bearing NETotic neutrophils/remnants accumulated in sites of interstitial renal fibrosis and in the subendothelial layer of AAAs. These data reveal the important pathogenic role of an Ang II/ROS/NET/TF axis in EH, linking thromboinflammation with endothelial dysfunction and fibrosis.

Authors

Akrivi Chrysanthopoulou, Eugenia Gkaliagkousi, Antonios Lazaridis, Stella Arelaki, Panagiotis Pateinakis, Maria Ntinopoulou, Alexandros Mitsios, Christina Antoniadou, Christos Argyriou, George S. Georgiadis, Vasileios Papadopoulos, Alexandra Giatromanolaki, Konstantinos Ritis, Panagiotis Skendros

×

Figure 1

Markers of NETs are detected both in plasma of patients with EH and in control neutrophils treated with EH plasma.

Options: View larger image (or click on image) Download as PowerPoint
Markers of NETs are detected both in plasma of patients with EH and in c...
(A) MPO-DNA complex levels and (B) CitH3 levels representing NET release in plasma from healthy individuals (controls, n = 26) and patients with EH (n = 55). For A and B, lines represent means accompanied by their ±95% CI, Student’s t test (2 tailed). (C) Correlation between MPO-DNA levels and CitH3 levels in 2 patients, Pearson’s correlation test. (D) Fluorescence microscopy images showing NE/CitH3 staining (blue: DAPI, green: NE, red: CitH3, original magnification, 1000×) and (E) percentage of NET release as assessed by immunofluorescence, in control neutrophils incubated with EH plasma and inhibited using diphenyleneiodonium (DPI; NADPH oxidase 2 inhibitor) or Cl-amidine (pan–protein arginine deiminase [pan-PAD] inhibitor). For D, a representative example of 6 independent experiments is shown. (F) MPO-DNA complex levels in NETs isolated from control neutrophils treated with EH plasma and inhibited with DPI or Cl-amidine. Red and green dots indicate values yielded from control neutrophils that had been incubated with EH plasma samples with higher or lower levels of NET markers, respectively. For D–F, ionomycin-stimulated neutrophils were used as positive controls. For E and F, data are from 6 independent experiments (mean ± SD, Friedman’s test). All conditions were compared to controls/untreated (statistically significant: P < 0.05; NS: not significant).

Copyright © 2022 American Society for Clinical Investigation
ISSN 2379-3708

Sign up for email alerts